Literature DB >> 21800092

High-resolution array CGH defines critical regions and candidate genes for microcephaly, abnormalities of the corpus callosum, and seizure phenotypes in patients with microdeletions of 1q43q44.

Blake C Ballif1, Jill A Rosenfeld, Ryan Traylor, Aaron Theisen, Patricia I Bader, Roger L Ladda, Susan L Sell, Michelle Steinraths, Urvashi Surti, Marianne McGuire, Shelley Williams, Sandra A Farrell, James Filiano, Rhonda E Schnur, Lauren B Coffey, Raymond C Tervo, Tracy Stroud, Michael Marble, Michael Netzloff, Kristen Hanson, Arthur S Aylsworth, J S Bamforth, Deepti Babu, Dmitriy M Niyazov, J Britt Ravnan, Roger A Schultz, Allen N Lamb, Beth S Torchia, Bassem A Bejjani, Lisa G Shaffer.   

Abstract

Microdeletions of 1q43q44 result in a recognizable clinical disorder characterized by moderate to severe intellectual disability (ID) with limited or no expressive speech, characteristic facial features, hand and foot anomalies, microcephaly (MIC), abnormalities (agenesis/hypogenesis) of the corpus callosum (ACC), and seizures (SZR). Critical regions have been proposed for some of the more prominent features of this disorder such as MIC and ACC, yet conflicting data have prevented precise determination of the causative genes. In this study, the largest of pure interstitial and terminal deletions of 1q43q44 to date, we characterized 22 individuals by high-resolution oligonucleotide microarray-based comparative genomic hybridization. We propose critical regions and candidate genes for the MIC, ACC, and SZR phenotypes associated with this microdeletion syndrome. Three cases with MIC had small overlapping or intragenic deletions of AKT3, an isoform of the protein kinase B family. The deletion of only AKT3 in two cases implicates haploinsufficiency of this gene in the MIC phenotype. Likewise, based on the smallest region of overlap among the affected individuals, we suggest a critical region for ACC that contains ZNF238, a transcriptional and chromatin regulator highly expressed in the developing and adult brain. Finally, we describe a critical region for the SZR phenotype which contains three genes (FAM36A, C1ORF199, and HNRNPU). Although ~90% of cases in this study and in the literature fit these proposed models, the existence of phenotypic variability suggests other mechanisms such as variable expressivity, incomplete penetrance, position effects, or multigenic factors could account for additional complexity in some cases.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21800092     DOI: 10.1007/s00439-011-1073-y

Source DB:  PubMed          Journal:  Hum Genet        ISSN: 0340-6717            Impact factor:   4.132


  25 in total

1.  Chromosome 1q42 deletion and agenesis of the corpus callosum.

Authors:  Mani J Puthuran; Christopher A Rowland-Hill; J Simpson; Peter W Pairaudeau; Jennifer L Mabbott; Steven M Morris; Yanick J Crow
Journal:  Am J Med Genet A       Date:  2005-09-15       Impact factor: 2.802

2.  Spatial and temporal expression of RP58, a novel zinc finger transcriptional repressor, in mouse brain.

Authors:  Chiaki Ohtaka-Maruyama; Akiko Miwa; Hitoshi Kawano; Masataka Kasai; Haruo Okado
Journal:  J Comp Neurol       Date:  2007-06-20       Impact factor: 3.215

3.  Role for Akt3/protein kinase Bgamma in attainment of normal brain size.

Authors:  Rachael M Easton; Han Cho; Kristin Roovers; Diana W Shineman; Moshe Mizrahi; Mark S Forman; Virginia M-Y Lee; Matthias Szabolcs; Ron de Jong; Tilman Oltersdorf; Thomas Ludwig; Argiris Efstratiadis; Morris J Birnbaum
Journal:  Mol Cell Biol       Date:  2005-03       Impact factor: 4.272

4.  A human protein kinase Bgamma with regulatory phosphorylation sites in the activation loop and in the C-terminal hydrophobic domain.

Authors:  D Brodbeck; P Cron; B A Hemmings
Journal:  J Biol Chem       Date:  1999-04-02       Impact factor: 5.157

5.  Corpus callosum abnormalities and the controversy about the candidate genes located in 1q44.

Authors:  C Orellana; M Roselló; S Monfort; S Oltra; R Quiroga; I Ferrer; F Martínez
Journal:  Cytogenet Genome Res       Date:  2010-01-27       Impact factor: 1.636

6.  Microdeletion of 6q16.1 encompassing EPHA7 in a child with mild neurological abnormalities and dysmorphic features: case report.

Authors:  Ryan N Traylor; Zheng Fan; Beth Hudson; Jill A Rosenfeld; Lisa G Shaffer; Beth S Torchia; Blake C Ballif
Journal:  Mol Cytogenet       Date:  2009-08-07       Impact factor: 2.009

Review 7.  Further delineation of the chromosome 14q terminal deletion syndrome.

Authors:  Clara D M van Karnebeek; Safira Quik; Sigrid Sluijter; Miriam M F Hulsbeek; Jan M N Hoovers; Raoul C M Hennekam
Journal:  Am J Med Genet       Date:  2002-06-01

Review 8.  A portrait of AKT kinases: human cancer and animal models depict a family with strong individualities.

Authors:  Alfonso Bellacosa; Joseph R Testa; Robert Moore; Lionel Larue
Journal:  Cancer Biol Ther       Date:  2004-03-11       Impact factor: 4.742

9.  A 2-Mb critical region implicated in the microcephaly associated with terminal 1q deletion syndrome.

Authors:  Anthony D Hill; Bernard S Chang; R Sean Hill; Levi A Garraway; Adria Bodell; William R Sellers; Christopher A Walsh
Journal:  Am J Med Genet A       Date:  2007-08-01       Impact factor: 2.802

10.  Mapping of deletion and translocation breakpoints in 1q44 implicates the serine/threonine kinase AKT3 in postnatal microcephaly and agenesis of the corpus callosum.

Authors:  Elena Boland; Jill Clayton-Smith; Victoria G Woo; Shane McKee; Forbes D C Manson; Livija Medne; Elaine Zackai; Eric A Swanson; David Fitzpatrick; Kathleen J Millen; Elliott H Sherr; William B Dobyns; Graeme C M Black
Journal:  Am J Hum Genet       Date:  2007-06-13       Impact factor: 11.025

View more
  45 in total

1.  Recent publications by ochsner authors.

Authors: 
Journal:  Ochsner J       Date:  2012

2.  Pre- and Postnatal Analysis of Chromosome 1q44 Deletion in Agenesis of Corpus Callosum.

Authors:  Mitesh Shetty; Ambika Srikanth; Jayarama Kadandale; Sridevi Hegde
Journal:  Mol Syndromol       Date:  2015-09-11

3.  Small posterior fossa in Chiari I malformation affected families is significantly linked to 1q43-44 and 12q23-24.11 using whole exome sequencing.

Authors:  Anthony M Musolf; Winson S C Ho; Kyle A Long; Zhengping Zhuang; Davis P Argersinger; Haiming Sun; Bilal A Moiz; Claire L Simpson; Elena G Mendelevich; Enver I Bogdanov; Joan E Bailey-Wilson; John D Heiss
Journal:  Eur J Hum Genet       Date:  2019-06-21       Impact factor: 4.246

4.  Syndromes Hidden within the 16p11.2 Deletion Region.

Authors:  Martin Poot
Journal:  Mol Syndromol       Date:  2018-07-13

Review 5.  Chromosomal Microarrays: Understanding Genetics of Neurodevelopmental Disorders and Congenital Anomalies.

Authors:  Jill A Rosenfeld; Ankita Patel
Journal:  J Pediatr Genet       Date:  2016-05-30

Review 6.  Connecting the CNTNAP2 Networks with Neurodevelopmental Disorders.

Authors:  Martin Poot
Journal:  Mol Syndromol       Date:  2015-02-03

7.  Adding Insult to Injury, Complexity to Intricacy.

Authors:  Martin Poot
Journal:  Mol Syndromol       Date:  2017-06-09

8.  HRPU-2, a Homolog of Mammalian hnRNP U, Regulates Synaptic Transmission by Controlling the Expression of SLO-2 Potassium Channel in Caenorhabditis elegans.

Authors:  Ping Liu; Sijie Jason Wang; Zhao-Wen Wang; Bojun Chen
Journal:  J Neurosci       Date:  2017-12-07       Impact factor: 6.167

9.  A de novo non-sense mutation in ZBTB18 in a patient with features of the 1q43q44 microdeletion syndrome.

Authors:  Sonja A de Munnik; Sixto García-Miñaúr; Alexander Hoischen; Bregje W van Bon; Kym M Boycott; Jeroen Schoots; Lies H Hoefsloot; Nine V A M Knoers; Ernie M H F Bongers; Han G Brunner
Journal:  Eur J Hum Genet       Date:  2013-11-06       Impact factor: 4.246

10.  Further Evidence of Contrasting Phenotypes Caused by Reciprocal Deletions and Duplications: Duplication of NSD1 Causes Growth Retardation and Microcephaly.

Authors:  J A Rosenfeld; K H Kim; B Angle; R Troxell; J L Gorski; M Westemeyer; M Frydman; Y Senturias; D Earl; B Torchia; R A Schultz; J W Ellison; K Tsuchiya; S Zimmerman; T A Smolarek; B C Ballif; L G Shaffer
Journal:  Mol Syndromol       Date:  2013-01-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.